In the visual pathway, when nerve fibers are damaged, degeneration can occur in two directions.
Wallerian degeneration (anterograde degeneration) is the process in which, when an axon is damaged, the axon degenerates distal to the injury site. The axonal skeleton and myelin sheath break down, and macrophages remove the degenerated debris. This is named after Augustus Waller, who first described it in 1850 in experiments cutting the glossopharyngeal and hypoglossal nerves of frogs.
Retrograde degeneration is a process in which the axon degenerates proximal to the injury site (toward the cell body). It leads to destruction of the cell body and cell death, and regeneration is impossible.
The optic nerve is embryologically derived from the diencephalon and is part of the central nervous system (CNS). Anterior to the lamina cribrosa, RGC (retinal ganglion cell) axons are unmyelinated, but posteriorly they become myelinated by oligodendrocytes. In peripheral nerves, one Schwann cell nourishes one axon, whereas in the CNS, one oligodendrocyte nourishes multiple axons.
In peripheral nerves, Schwann cells promote regeneration via growth factors. In contrast, in the CNS, the regeneration-promoting effect of oligodendrocytes is weak, and axonal regeneration in the mature CNS is extremely poor.
Demyelination refers to a condition in which the myelin sheath primarily degenerates and is lost. Rapid demyelination often accompanies axonal degeneration. Representative demyelinating diseases include multiple sclerosis, neuromyelitis optica, and leukodystrophy.
QWhat is the difference between Wallerian degeneration and retrograde degeneration?
A
Wallerian degeneration occurs distal to the site of axonal injury, while retrograde degeneration occurs proximal to the injury (toward the cell body). Retrograde degeneration leads to cell body death and irreversible damage, whereas Wallerian degeneration in peripheral nerves may leave room for regeneration. Both often occur together after the same injury.
The pattern of symptoms varies depending on the site of damage.
Decreased visual acuity: Can occur with damage at any point along the visual pathway. Often progressive.
Visual field defects: Show patterns specific to the site of damage. Optic nerve: unilateral decreased vision or scotoma. Optic chiasm: bitemporal hemianopia. Optic tract: contralateral homonymous hemianopia (incongruous, incomplete). Lateral geniculate body: segmental, sector-shaped homonymous hemianopia.
Color vision abnormalities: Acquired color vision defects may occur with optic nerve disorders. Acquired third color vision deficiency (blue-yellow type) may be observed.
The time course of optic nerve atrophy and degeneration is an important finding.
Wallerian Degeneration
Course after injury: Degeneration begins within 24 hours of nerve injury. It takes approximately 7 days for the breakdown of the axonal skeleton and myelin sheath to complete.
Spared proximal optic nerve: Axons proximal to the injury site may appear normal and function for 3–4 weeks.
Fundus findings: The optic disc, distal to the injury, becomes atrophic and pale over weeks to months.
Retrograde degeneration
Timing of RGC death: Retinal ganglion cell (RGC) death may occur 6–8 weeks after injury.
Pattern after optic tract lesion: On the affected side, temporal optic disc pallor with arcuate nerve fiber layer defects. On the contralateral side, band atrophy occurs. Appears over about one month.
Trans-synaptic degeneration: Damage to the LGN (lateral geniculate nucleus) or visual cortex can cause optic atrophy. Usually occurs more easily with occipital lobe damage during fetal or early infant periods1).
Fundus findings in optic atrophy vary in morphology depending on the cause.
Simple atrophy (primary): Due to retrobulbar visual pathway disorders. Well-defined margins, pallor, flatness, shallow cupping, narrowing of superficial vessels. Caused by retrobulbar optic neuritis, compressive lesions, Leber hereditary optic neuropathy, toxic/drug-induced optic neuropathy.
Inflammatory atrophy (secondary): Occurs after optic disc swelling. Characterized by glial proliferation, blurred margins, and decreased small blood vessels. Caused by anterior ischemic optic neuropathy, optic neuritis, or uveitis.
Glaucomatous optic atrophy: Features vertical enlargement of a deep cup, notching, and backward bowing of the lamina cribrosa.
Retinal atrophy: Waxy yellow-white appearance. Caused by retinal degenerative diseases or retinal circulatory disorders.
RAPD (relative afferent pupillary defect): In optic tract lesions, RAPD may be observed in the contralateral eye. Lesions beyond the lateral geniculate body do not affect the pupillary light reflex.
MRI findings: Wallerian degeneration is detected as T2 hyperintensity on T2-weighted images (suggesting gliosis). In the acute phase, diffusion restriction is observed on diffusion-weighted imaging (DWI)1)2).
Kihira et al. (2021) reported a case of progressive left visual acuity loss over 5 years in a 47-year-old woman1). Optical coherence tomography (OCT) confirmed left optic atrophy, and T2 hyperintensity along the left optic radiation was detected on MRI T2-weighted images. This case is notable as a report of trans-synaptic degeneration from optic atrophy without associated infarction or inflammatory disease.
QHow long does it take for optic atrophy to become detectable on fundus examination?
A
Wallerian degeneration begins within 24 hours after injury, but the proximal portion of the axon may appear normal for 3–4 weeks. Retrograde degeneration leading to RGC death can occur within 6–8 weeks. It often takes several weeks to months after injury for optic disc pallor to become clearly visible on fundus examination.
The characteristics of each causative disease are supplemented below.
Glaucoma: One of the most frequent causes. Elevated intraocular pressure causes degeneration of RGC axons, leading to irreversible visual impairment. Both anterograde and retrograde axonal transport are blocked at the lamina cribrosa of the optic nerve head (ONH)4).
Compressive lesions: Pituitary adenomas, craniopharyngiomas, aneurysms, etc., compress the optic chiasm or optic tract. Visual function may improve after decompression, but if optic atrophy is evident, the visual prognosis is often poor.
Cerebrovascular disorders: Both ischemic and hemorrhagic strokes cause Wallerian degeneration of the visual pathway. The degree of cerebral peduncle atrophy correlates with the extent of brain damage2).
Neurodegenerative diseases: In Alzheimer’s disease (AD), brain lesions can affect the visual pathway and cause retrograde degeneration. This is detected as thinning of the retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) on OCT5).
Arachnoid cysts and cerebral cortical hypoplasia: Can cause Wallerian degeneration due to congenital compression2).
The basic step is to confirm optic atrophy (pale optic disc). There are two pathways: one that progresses from optic disc swelling to atrophy, and another that directly progresses from a normal optic disc to atrophy.
OCT plays a central role in the quantitative evaluation of optic atrophy.
cpRNFL thickness measurement (circumpapillary retinal nerve fiber layer thickness): Indirectly evaluates all RGCs. Reliability may decrease in the acute phase when optic disc swelling is present.
Macular GCC (ganglion cell complex)/GC-IPL thickness measurement: Can directly evaluate RGC damage. It is less affected by optic disc swelling and may detect thinning earlier than cpRNFL.
Individual variation in normal values: Normal thickness varies greatly among individuals, so follow-up with actual measurements and comparison with the fellow eye are important.
Comprehensive evaluation: OCT findings should be interpreted while confirming consistency with visual field, fundus findings, and other visual function tests.
OCT angiography (OCTA): Non-invasively visualizes the fine structure of retinal and choroidal vessels. It has been reported that decreased vessel density in radial peripapillary capillaries (RPCs) corresponds to areas of nerve fiber layer defects.
Quantification of degeneration, predictor of functional recovery (subacute ischemic phase) 2)
T2 hyperintensity of the optic radiation requires differentiation from leukomalacia, prior infarction, and demyelinating diseases (multiple sclerosis)1).
Visual field testing: Useful for identifying the site of damage. Optic nerve lesions show central scotoma/cecocentral scotoma, optic chiasm lesions show bitemporal hemianopia, and optic tract lesions show contralateral homonymous hemianopia.
RAPD (relative afferent pupillary defect): Optic tract lesions may cause RAPD in the contralateral eye. Lesions posterior to the lateral geniculate body do not affect the pupillary light reflex.
Central flicker value: A useful auxiliary test for diagnosing optic nerve diseases.
QHow is optic atrophy evaluated using OCT?
A
Measurement of cpRNFL thickness and macular GCC thickness is central. In the acute phase with optic disc swelling, GCC analysis has the advantage of detecting thinning earlier than cpRNFL. Normal values vary greatly among individuals, so follow-up with actual measurements and comparison with the fellow eye are important. Consistency checks with visual field, fundus findings, and other visual function tests are also essential.
Currently, there is no proven regenerative therapy for Wallerian degeneration or retrograde degeneration of the optic pathway. Treatment primarily focuses on the underlying disease.
Glaucoma: Intraocular pressure-lowering therapy (eye drops, surgery) is the mainstay. Early intervention may slow the progression of degeneration.
Optic disc edema and papilledema: Treatment of the primary disease (cause of increased intracranial pressure).
Compressive lesions (tumors, aneurysms): Visual function may improve after decompression. However, once optic atrophy is already evident, the prognosis for visual function is often poor.
Nasal optic neuropathy: In addition to surgical curettage of sinus lesions, optic canal decompression is performed as needed.
Oral vitamin B12: May be administered in long-standing cases.
Circulatory enhancers: Administration is considered when circulatory insufficiency is suspected.
Hereditary optic neuropathies (ADOA, LHON, Wolfram syndrome): Currently, there is no effective curative treatment; low vision care and patient counseling are the mainstays.
6. Pathophysiology and Detailed Mechanisms of Onset
After axonal injury, the distal side undergoes breakdown of the axonal skeleton and myelin sheath, and macrophages remove debris (Wallerian degeneration). In peripheral nerves, Schwann cells promote regeneration via growth factors. In the CNS, the regenerative-promoting effect of oligodendrocytes is weak, and axonal regeneration in the mature central nervous system is poor or impossible.
In retrograde degeneration, the axon degenerates proximal to the injury site, leading to cell body destruction and cell death. Retrograde RGC atrophy after optic tract damage is inevitable, and RGC death can occur within 6 to 8 weeks.
Like CNS neurons, RGCs exhibit axonal degeneration, myelin breakdown, scar formation, and secondary degeneration, with limited regenerative capacity after injury5).
Transport within axons (axonal transport) is classified by direction and speed.
Anterograde Transport
Fast transport: 400–1,000 mm/day. Involved in transport of membrane components such as synaptic vesicles.
Intermediate-speed transport: 5–400 mm/day.
Slow transport: 0.5–5 mm/day. Involved in transporting proteins necessary for axon maintenance.
Retrograde transport
Speed: 50–300 mm/day.
Function: Involved in transmitting information from the periphery to the cell body and recycling waste products.
Mitochondria: Damaged or aged mitochondria are transported retrogradely back to the RGC cell body for “recharging.” In glaucoma, axonal transport is impaired at the lamina cribrosa, leading to progressive optic atrophy.
In glaucoma, RGC axons are most susceptible to damage at the lamina cribrosa of the optic nerve head (ONH)4).
Pitha et al. (2024) reported detailed mechanisms of RGC axonal damage in glaucoma4). Mechanical stress from intraocular pressure is significantly greater at the ONH (lamina cribrosa) than in the retina, with circumferential hoop stress and translaminar pressure difference acting on RGC axons. Large αRGCs (especially OFF-type) are more selectively vulnerable, and large RGC axons passing through the superior and inferior poles of the ONH are preferentially damaged.
The pathway by which mechanical stress at the lamina cribrosa blocks axonal transport is as follows.
Axonal transport impairment: Both anterograde and retrograde axonal transport are blocked at the ONH. Impaired axonal transport of neurotrophic factors (BDNF, NGF) induces apoptosis4).
JNK stress response pathway: c-Jun is upregulated in RGCs and astrocytes. Jnk2/Jnk3 knockout mice show improved RGC survival 4).
Mechanosensitive channels: TRPV1 (RGC death via Ca²⁺ influx), Piezo 1&2 (Ca²⁺ transmission), and pannexin-1 are involved 4).
Mitochondrial dysfunction: Intraocular pressure stress reduces mitochondrial movement in the ONH4).
Glutamate excitotoxicity: Axonal transport impairment decreases neurotrophic factors and increases extracellular glutamate concentration, promoting RGCapoptosis.
The phenomenon where neuronal degeneration on one side of a synapse affects the other side across the synapse is called “trans-synaptic degeneration.” Cases have been reported where degeneration spreads from optic atrophy to the optic radiation1), and retrograde trans-synaptic degeneration after occipital lobe stroke (Jindahra et al., 2012) is also known1). It is generally thought to occur more frequently with occipital lobe damage during the fetal or early infant period.
In Alzheimer’s disease (AD), brain lesions affecting neural connections in the visual pathway may cause thinning of the RNFL and GC-IPL 5). However, in the posterior cortical atrophy variant of AD, differences in peripapillary RNFL compared to controls have been reported to be difficult to distinguish 5).
QWhy is the optic nerve head selectively damaged in glaucoma?
A
Mechanical stress from intraocular pressure is significantly greater at the ONH (lamina cribrosa) than in the retina. Circumferential hoop stress and translaminar pressure gradient act on axons, blocking both anterograde and retrograde axonal transport 4). This mechanical load promotes RGCapoptosis through a combination of mechanisms including neurotrophic factor deprivation, mitochondrial dysfunction, and calcium influx.
7. Latest Research and Future Prospects (Research-Stage Reports)
Research is advancing on using fractional anisotropy (FA) values from diffusion tensor imaging (DTI) to quantify Wallerian degeneration in the subacute phase after stroke and predict functional recovery 2). The degree of cerebral peduncle atrophy has been shown to correlate with the extent of brain damage, and its clinical application as an imaging biomarker is anticipated 2).
Hustings & Lemmerling (2021) systematically reported MRI findings of Wallerian degeneration due to various causes including ischemic stroke, hemorrhagic stroke, brain tumor, trauma, arachnoid cyst, and cerebral cortical hypoplasia 2). They emphasized that careful interpretation based on clinical context is necessary in the acute phase to avoid misidentification as secondary infarction.
In experimental models of rats carrying the Wallerian degeneration slow (WLDS) gene, a primary axonal protective effect was demonstrated. However, retrograde degeneration still occurred, ultimately leading to cell body death. This model is used as a basic tool to separately evaluate axonal protection therapy and cell body protection therapy.
In Vivo Diagnosis of Schnabel Cavernous Optic Atrophy (SCONA) Using SD-OCT
Weber et al. (2025) published the first report correlating SD-OCT and histopathological findings in Schnabel cavernous optic atrophy (SCONA)3). Previously, SCONA could only be diagnosed histologically, but they demonstrated that it can be detected in vivo as a hyporeflective pseudocyst within the lamina cribrosa using the ONH-RC scan of the BMO-MRW modality. The prevalence in histological studies of elderly individuals is reported to be approximately 1.7–2.1%3), and it is expected to serve as a new diagnostic tool for differentiating from glaucomatous optic atrophy.
Potential for Neuroprotection and Regenerative Medicine
JNK inhibitors, TRPV1 channel inhibitors, glutamate antagonists: These are under investigation as candidate therapeutic agents for protecting retinal ganglion cells in glaucoma4).
Regenerative medicine using iPS cells: Regenerative medicine approaches using iPS cells for optic atrophy are being researched as future treatment options.
Kihira S, Arnold AC, Pawha PS, Villablanca P, Nael K. Trans-synaptic degeneration of the optic radiation from optic nerve atrophy. Radiology Case Reports. 2021;16:855-857.
Hustings N, Lemmerling M. MRI of Wallerian Degeneration in the Brainstem: A Pictorial Essay. Journal of the Belgian Society of Radiology. 2021;105(1):58, 1-6.
Weber C, Mercieca K, Weller JM, Bulirsch LM, Ach T, Holz FG, Loeffler KU, Herwig-Carl MC. SD-OCT-histopathologic correlation in Schnabel’s cavernous optic nerve atrophy. Eye. 2025;39:1203-1210.
Pitha I, Kambhampati S, Oglesby E, Bhatt A, Quigley HA. [Review: Mechanosensitive channels and 眼圧 effects on RGC axons at the ONH]. Progress in Retinal and Eye Research. 2024. (Author manuscript, PMC 2024)
Cheung CY, Mok V, Foster PJ, Trucco E, Chen C, Wong TY. Retinal imaging in Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2021;92:983-994.
Copy the article text and paste it into your preferred AI assistant.
Article copied to clipboard
Open an AI assistant below and paste the copied text into the chat box.